Eltrombopag for the treatment of refractory thrombocytopenia associated with connective tissue disease
Abstract To assess the efficacy and safety of eltrombopag in connective tissue disease (CTD)-immune thrombocytopenia (ITP), we conducted this single-center retrospective observational study, including patients with refractory CTD-ITP who were treated with eltrombopag between January 2018 and August...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/efe7af08d0f3455089981a6d8628972c |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|